ArticleThe pharmacogenomics journal2018

A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.

M E Moretti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.